← Back to Analyst Consensus 
AUPH Buy
Aurinia Pharmaceuticals Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Aug 7, 2026 | RBC Capital | maintain | Sector Perform → Sector Perform | — | 55% |
| Dec 3, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $16 | 50% |
| Nov 7, 2025 | Jefferies | upgrade | Hold → Buy | $21 | 52% |
| Nov 5, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $15 | 55% |
| Aug 1, 2025 | RBC Capital | maintain | Outperform → Outperform | $9 | 55% |
| Sep 16, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $10 | 50% |
| Sep 9, 2024 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $10 | 50% |
| Sep 6, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Mar 1, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $13 | 44% |
| Feb 23, 2024 | Cantor Fitzgerald | maintain | Overweight → Overweight | $10 | 50% |
| Feb 22, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $13 | 44% |
| Feb 16, 2024 | RBC Capital | maintain | Outperform → Outperform | $8 | 55% |
| Sep 22, 2023 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Aug 7, 2023 | HC Wainwright& Co. | maintain | Buy → Buy | $15 | — |
| Jul 6, 2023 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $15 | 50% |
| May 3, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $14 | 44% |
| Feb 23, 2023 | RBC Capital | reiterate | — → Outperform | $11 | 55% |
| Jan 4, 2023 | RBC Capital | maintain | — → Outperform | $11 | 55% |
| Nov 7, 2022 | HC Wainwright & Co. | maintain | — → Buy | $14 | 44% |
| Nov 4, 2022 | RBC Capital | maintain | — → Outperform | $10 | 55% |
| Nov 4, 2022 | Oppenheimer | downgrade | Outperform → Perform | $0 | 52% |
| Nov 4, 2022 | SVB Leerink | maintain | — → Outperform | $12 | — |
| Aug 9, 2022 | HC Wainwright & Co. | maintain | — → Buy | $26 | 44% |
| Aug 8, 2022 | Oppenheimer | maintain | — → Outperform | $13 | 52% |
| May 5, 2022 | HC Wainwright & Co. | maintain | — → Buy | $30 | 44% |
| Apr 28, 2022 | RBC Capital | maintain | — → Outperform | $22 | 55% |
| Mar 8, 2022 | SVB Leerink | maintain | — → Outperform | $22 | — |
| Mar 1, 2022 | RBC Capital | maintain | — → Outperform | $27 | 55% |
| Feb 23, 2022 | RBC Capital | maintain | — → Outperform | $31 | 55% |
| Dec 10, 2021 | Oppenheimer | upgrade | Perform → Outperform | $31 | 52% |
| Nov 4, 2021 | Oppenheimer | maintain | — → Perform | $33 | 52% |
| Nov 4, 2021 | HC Wainwright & Co. | maintain | — → Buy | $40 | 44% |
| Nov 4, 2021 | SVB Leerink | maintain | — → Outperform | $35 | — |
| Oct 28, 2021 | Oppenheimer | downgrade | Outperform → Perform | $32 | 52% |
| Oct 26, 2021 | RBC Capital | maintain | — → Outperform | $34 | 55% |
| Jan 27, 2021 | SVB Leerink | maintain | — → Outperform | $28 | — |
| Jan 25, 2021 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Nov 3, 2020 | HC Wainwright & Co. | maintain | — → Buy | $28 | 44% |
| Aug 12, 2020 | HC Wainwright & Co. | maintain | — → Buy | $34 | 44% |
| Jul 22, 2020 | HC Wainwright & Co. | maintain | — → Buy | $33 | 44% |
| Mar 6, 2020 | Cantor Fitzgerald | maintain | — → Overweight | $32 | 50% |
| Dec 16, 2019 | HC Wainwright & Co. | maintain | — → Buy | $32 | 44% |
| Sep 10, 2019 | Oppenheimer | initiate | — → Outperform | $14 | 52% |
| Mar 20, 2019 | Raymond James | maintain | — → Outperform | $11 | 54% |
| Feb 8, 2018 | RBC Capital | initiate | — → Outperform | $9 | 55% |
| Oct 23, 2017 | Leerink Swann | maintain | — → Outperform | $14 | — |
| Oct 6, 2017 | Seaport Global | initiate | — → Buy | $10 | 51% |
| Sep 13, 2017 | Canaccord Genuity | downgrade | Buy → Speculative Buy | $0 | 48% |
| Apr 10, 2017 | Cantor Fitzgerald | initiate | — → Overweight | $14 | 50% |
Price Target Trend
Apr 25, 2026 Latest: $18 Oct 24, 2026
EPS Estimates
0q $0.22
Lo: $0.21 Hi: $0.25
5 analysts ▲1
0y $0.95
Lo: $0.90 Hi: $1.01
5 analysts ▲1
+1y $1.17
Lo: $0.68 Hi: $1.64
5 analysts ▲1
+1q $0.21
Lo: $0.16 Hi: $0.25
5 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days